Cognex drops as insider-sale overhang and auditor switch keep sentiment cautious
Cognex shares slid as investors continued to price in heavy recent insider selling and a fading post-rally bid into late March. The stock has also been under pressure after a 2026 auditor switch disclosed in an SEC filing, keeping sentiment cautious into the next earnings cycle.
1. What’s moving the stock
Cognex (CGNX) is trading lower as the market continues to digest a wave of insider selling disclosed in late February and early March, which has acted as an overhang on the shares even on otherwise quiet news days. Multiple trackers show notable net insider sales over recent months, including a reported March 2 sale by a senior executive, reinforcing a “sell-the-rips” tone in the stock. (insiderscreener.com)
2. Auditor change adds another headline for investors to handicap
Separately, investors have been weighing Cognex’s disclosed auditor transition for the fiscal year ending December 31, 2026, with KPMG selected to replace Grant Thornton after completion of the 2025 audit. While auditor changes can be routine, they often increase near-term uncertainty for investors around process, controls, and the cadence of future filings—particularly when a stock is already under pressure. (stocktitan.net)
3. Setup into upcoming catalysts
With the next earnings release approaching, traders appear sensitive to positioning and headline risk, especially after recent volatility in the name. Company materials and earnings-calendar listings indicate Cognex’s earnings are scheduled for April 29, 2026, before the opening bell, which may be keeping investors cautious ahead of the print. (api.mziq.com)